Zacks.com on MSN
NRx Pharmaceuticals to Post Q4 Earnings: How to Play the Stock?
NRx Pharmaceuticals NRXP is expected to report its fourth-quarter 2024 results soon. The Zacks Consensus Estimate for NRXP’s ...
Cardinal said the acquisition doubles the number of final-mile deliveries it can handle annually to 1.1 million from 550,000. “This acquisition is part of Cardinal’s growing commitment to serving the ...
Aviptadil has gone 0 for 2 on emergency use authorization filings at the FDA. The new rejection is the latest in a series of blows to the COVID-19 candidate, driving NRx Pharmaceuticals to shift focus ...
NRx Pharmaceuticals (NASDAQ:NRXP – Get Free Report) will likely be releasing its earnings data after the market closes on Wednesday, March 26th. Analysts expect NRx Pharmaceuticals to post earnings of ...
We recently compiled a list of the 12 Best Psychedelic Stocks to Buy in 2025. In this article, we are going to take a look at where NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) stands against the other ...
NRX-100, preservative free, IV ketamine, is designed to avoid potential toxicity concerns linked to benzethonium chloride, used in currently available formulations of ketamine Filing strengthens NRx's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results